LXRX
LEXICON PHARMACEUTICALS, INC.
Key Financials
Net Income
$-50341000
↑ 74.9%
Operating Income
$-48911000
↑ 75.2%
Revenue
$49.8M
↑ 60.2%
EPS (Diluted)
$-0.14
↑ 77.8%
Cash & Equivalents
$34.3M
↓ 48.5%
Total Assets
$185.0M
↓ 38.0%
Total Liabilities
$77.4M
↓ 49.2%
Shareholders' Equity
$107.5M
↓ 26.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| EFFECT | 8/14/2026 | View on SEC |
| S-3 | 8/6/2026 | View on SEC |
| S-8 | 8/6/2026 | View on SEC |
| 10-Q | 8/6/2026 | View on SEC |
| SCHEDULE 13G/A | 8/6/2026 | View on SEC |
| 8-K | 8/6/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | LXRX |
| Company Name | LEXICON PHARMACEUTICALS, INC. |
| CIK | 1062822 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 2818633000 |